My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 346

    1.

    Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.

    Ruggenenti P, Flores C, Aros C, Ene-Iordache B, Trevisan R, Ottomano C, Remuzzi G.

    Diabetes Care. 2003 Feb;26(2):502-9.PMID: 12547889 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

    Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT.

    Diabetes Care. 2001 May;24(5):886-90.PMID: 11347749 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

    Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

    Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

    J Nephrol. 2001 Nov-Dec;14(6):461-71.PMID: 11783602 [PubMed - indexed for MEDLINE]Related articles

    5.

    A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.

    Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH.

    Clin Ther. 2006 Oct;28(10):1649-57.PMID: 17157120 [PubMed - indexed for MEDLINE]Related articles

    6.

    Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

    Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S.

    Diabetes. 1999 Jan;48(1):99-105.PMID: 9892228 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

    Ciofetta M, Lalli C, Del Sindaco P, Torlone E, Pampanelli S, Mauro L, Chiara DL, Brunetti P, Bolli GB.

    Diabetes Care. 1999 May;22(5):795-800.PMID: 10332684 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.

    Annuzzi G, Del Prato S, Arcari R, Bellomo Damato A, Benzi L, Bruttomesso D, Calderini MC, Coscelli C, Fedele D, Galluzzo A, Giordano M, Giorgino R, Lapolla A, Orsini P, Pagano G, Santoro D, Riccardi G.

    Nutr Metab Cardiovasc Dis. 2001 Jun;11(3):168-75.PMID: 11590992 [PubMed - indexed for MEDLINE]Related articles

    9.

    Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

    Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

    Clin Ther. 2000 Feb;22(2):222-30.PMID: 10743981 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

    Tuttle KR, Bruton JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA.

    N Engl J Med. 1991 Jun 6;324(23):1626-32. Erratum in: N Engl J Med 1991 Dec 5;325(23):1666. PMID: 2030719 [PubMed - indexed for MEDLINE]Related articles

    11.

    Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.

    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.

    J Diabetes Complications. 2007 Jan-Feb;21(1):20-7.PMID: 17189870 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

    Rassam AG, Zeise TM, Burge MR, Schade DS.

    Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

    Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.

    Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60.PMID: 14737746 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes.

    Velussi M.

    Diabetes Nutr Metab. 2002 Apr;15(2):96-100.PMID: 12059098 [PubMed - indexed for MEDLINE]Related articles

    15.

    Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

    Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

    Diabetes Care. 2002 May;25(5):883-8.PMID: 11978685 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.

    Amador-Licona N, Guízar-Mendoza J, Vargas E, Sánchez-Camargo G, Zamora-Mata L.

    Arch Med Res. 2000 Nov-Dec;31(6):571-5.PMID: 11257323 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

    Koivisto VA, Tuominen JA, Ebeling P.

    Diabetes Care. 1999 Mar;22(3):459-62.PMID: 10097929 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Insulin lispro lowers postprandial glucose in prepubertal children with diabetes.

    Deeb LC, Holcombe JH, Brunelle R, Zalani S, Brink S, Jenner M, Kitson H, Perlman K, Spencer M.

    Pediatrics. 2001 Nov;108(5):1175-9.PMID: 11694699 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

    Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA.

    Diabetes Care. 1998 Apr;21(4):570-3.PMID: 9571344 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity